Biomedical Engineering Reference
In-Depth Information
60. Vernengo J et al (2008) Evaluation of novel injectable hydrogels for nucleus pulposus
replacement. J Biomed Mater Res B Appl Biomater 84(1):64-69
61. Boyd LM, Carter AJ (2006) Injectable biomaterials and vertebral endplate treatment for
repair and regeneration of the intervertebral disc. Eur Spine J 15(Suppl 3):S414-S421
62. Wardlaw D (2008) BioDisc nucleus pulposus replacement. In: Yue J, Bertagnoli R, McAfee
P, An H (eds) Motion preservation surgery of the spine: advanced techniques and
controversies. Elsevier, Philadelphia, pp 431-441
63. Bertagnoli R, Schonmayr R (2002) Surgical and clinical results with the PDN prosthetic disc-
nucleus device. Eur Spine J 11(Suppl 2):S143-S148
64. Bertagnoli R et al (2005) Mechanical testing of a novel hydrogel nucleus replacement
implant. Spine J 5(6):672-681
65. Joshi A et al (2006) Functional compressive mechanics of a PVA/PVP nucleus pulposus
replacement. Biomaterials 27(2):176-184
66. Thomas J et al (2004) The effect of dehydration history on PVA/PVP hydrogels for nucleus
pulposus replacement. J Biomed Mater Res B Appl Biomater 69(2):135-140
67. Thomas J, Lowman A, Marcolongo M (2003) Novel associated hydrogels for nucleus
pulposus replacement. J Biomed Mater Res A 67(4):1329-1337
68. Bao QB, Bagga CS, Higham PA (1997) Swelling pressure of hydrogel: a perceived benefit for
a spinal prosthetic nucleus. In: Proceedings 10th annual meeting of the International
Intradiscal Therapy Society, Naples, FL
69. Boelen EJ et al (2005) Intrinsically radiopaque hydrogels for nucleus pulposus replacement.
Biomaterials 26(33):6674-6683
70. Lau S, Lam K (2007) Lumbar stabilisation techniques. Curr Orthop 21:25-39
71. Laurencin CT et al (1999) Tissue engineering: orthopedic applications. Annu Rev Biomed
Eng 1:19-46
72. Nerem RM, Sambanis A (1995) Tissue engineering: from biology to biological substitutes.
Tissue Eng 1(1):3-13
73. Halloran DO et al (2008) An injectable cross-linked scaffold for nucleus pulposus regenera-
tion. Biomaterials 29(4):438-447
74. Richardson SM et al (2008) Human mesenchymal stem cell differentiation to NP-like cells in
chitosan-glycerophosphate hydrogels. Biomaterials 29(1):85-93
75. Chan S, Lam S, Leung V, Chan D, Luk K, Cheung K (2010) Minimizing cryopreservation-
induced loss of disc cell activity for storage of whole intervertebral discs. Eur Cells Mater
19:273-283
76. Ganey T et al (2003) Disc chondrocyte transplantation in a canine model: a treatment for
degenerated or damaged intervertebral disc. Spine (Phila Pa 1976) 28(23):2609-2620
77. Gorensek M et al (2004) Nucleus pulposus repair with cultured autologous elastic cartilage
derived chondrocytes. Cell Mol Biol Lett 9(2):363-373
78. Bae H, Kanim M, Zhao L (2008) Human fetal chondrocyte transplants for damaged interver-
tebral disc. Spine J 8(5):928-938
79. Kaneyama S et al (2008) Fas ligand expression on human nucleus pulposus cells decreases
with disc degeneration processes. J Orthop Sci 13(2):130-135
80. Takada T et al (2002) Fas ligand exists on intervertebral disc cells: a potential molecular
mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 27(14):1526-1530
81. Wolfe HJ, Putschar WG, Vickery AL (1965) Role of the notochord in human intervetebral
disk. I. Fetus and infant. Clin Orthop Relat Res 39:205-212
82. Cappello R et al (2006) Notochordal cell produce and assemble extracellular matrix in a
distinct manner, which may be responsible for the maintenance of healthy nucleus pulposus.
Spine (Phila Pa 1976) 31(8):873-882, discussion 883
83. Erwin WM et al (2006) Nucleus pulposus notochord cells secrete connective tissue growth
factor and up-regulate proteoglycan expression by intervertebral disc chondrocytes. Arthritis
Rheum 54(12):3859-3867
